However, the accumulation of liver lipids in NASH patients was related to the decrease of ABCA1 expression level, and up-regulation of SR-B1 expression can promote the reverse transport of liver cholesterol and accelerate cholesterol metabolism (Yang et al., 2010; Xin et al., 2013). Here, SCARB1 is linked to metabolic dysfunction-associated steatohepatitis.